61 NORTH BEACON STREET, BOSTON, MA
Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
Investor Presentation
Announces Positive Outcome from FDA Type C Meeting
Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors
Amended material disclosure
Material disclosure
Annual Report to Security Holders
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Correspondence
Submission Upload